Neratinib plus dasatinib is highly synergistic in HER2-positive breast cancer in vitro and in vivo
-
Published:2024-11
Issue:
Volume:49
Page:102073
-
ISSN:1936-5233
-
Container-title:Translational Oncology
-
language:en
-
Short-container-title:Translational Oncology
Author:
Conlon Neil TORCID,
Roche Sandra,
Mahdi Amira F,
Browne Alacoque,
Breen LauraORCID,
Gaubatz Johanna,
Meiller Justine,
O'Neill Fiona,
O'Driscoll Lorraine,
Cremona Mattia,
Hennessy Bryan T,
Eli Lisa DORCID,
Crown John,
Collins Denis MORCID